Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)
Clinical trial NCT03632993 · COMPLETED
Trial details
- NCT number
- NCT03632993
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-18
- Primary completion
- 2019-01-24
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.